I‐Ting Teng
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- SARS-CoV-2 and COVID-19 Research 34
- Virology 9
- HIV Research and Treatment 9
- Co-authors
- Weihong Tan (18 shared papers)Liqin Zhang (12 shared papers)Cheng Cui (8 shared papers)Sena Cansız (8 shared papers)Cuichen Sam Wu (8 shared papers)Weijia Hou (7 shared papers)Juan Li (2 shared papers)Yanyue Wang (5 shared papers)
- Journals
- Cell Reports (6 papers)Journal of the American Chemical Society (6 papers)Nature Communications (6 papers)Cell (5 papers)Science Translational Medicine (4 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
I‐Ting Teng
67 papers receiving 5k citations
I‐Ting Teng's Hit Papers
Peers
Comparison fields: 5 of 101
- Infectious Diseases 2.1k
- Biomaterials 443
- Molecular Biology 2k
- Virology 112
- Molecular Medicine 100
Countries citing papers authored by I‐Ting Teng
This map shows the geographic impact of I‐Ting Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Ting Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Ting Teng more than expected).
Fields of papers citing papers by I‐Ting Teng
This network shows the impact of papers produced by I‐Ting Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Ting Teng. The network helps show where I‐Ting Teng may publish in the future.
Co-authors
The 25 scholars most cited alongside I‐Ting Teng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates Hit paper breakdown → | 2020 | 864 |
| 2 | 2015 | 467 | |
| 3 | 2017 | 436 | |
| 4 | 2015 | 308 | |
| 5 | 2020 | 285 | |
| 6 | 2010 | 228 | |
| 7 | 2021 | 223 | |
| 8 | 2015 | 189 | |
| 9 | 2021 | 185 | |
| 10 | mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron Hit paper breakdown → | 2022 | 169 |
| 11 | 2021 | 162 | |
| 12 | 2022 | 134 | |
| 13 | 2015 | 126 | |
| 14 | 2015 | 110 | |
| 15 | 2016 | 90 | |
| 16 | 2016 | 84 | |
| 17 | 2013 | 77 | |
| 18 | 2018 | 64 | |
| 19 | 2021 | 59 | |
| 20 | 2020 | 58 |
About I‐Ting Teng
I‐Ting Teng is a scholar working on Infectious Diseases, Virology, Molecular Biology, Biomaterials and Epidemiology, having authored 72 papers that have together received 5.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (34 papers), Advanced biosensing and bioanalysis techniques (12 papers), HIV Research and Treatment (9 papers), RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Malaria Research and Control (3 papers), Virology and Viral Diseases (3 papers) and RNA and protein synthesis mechanisms (2 papers). The work is most often cited by research in Infectious Diseases (2.1k citations), Biomaterials (443 citations), Molecular Biology (2k citations), Virology (112 citations) and Molecular Medicine (100 citations). I‐Ting Teng has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Weihong Tan, Liqin Zhang, Cheng Cui, Sena Cansız, Cuichen Sam Wu, Weijia Hou, Juan Li, Yanyue Wang, Ren Cai and Yuan Wu. Their work appears in journals such as Cell Reports, Journal of the American Chemical Society, Nature Communications, Cell and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.